MyFinsight
Home
About
Contact
crvs: the income statement
Download
Download image
Comprehensive loss
-$10,069K
Cumulative foreign
currency translation...
$59K
Unrealized gain (loss) on
marketable securities
$29K
Net loss
-$10,157K
Loss from equity
method investment
-$323K
Loss before equity
method investment
-$9,834K
Interest income and other
expense, net
$738K
Loss from operations
-$10,572K
Total operating
expenses
$10,572K
General and
administrative
$2,118K
Research and development
$8,454K
Back
Back
Income Statement
source: myfinsight.com
Corvus Pharmaceuticals, Inc. (CRVS)
Corvus Pharmaceuticals, Inc. (CRVS)